Cancer Family
Trophoblastic Tumor
CI-CAN-00000376Explore in graph →
Non-malignant12 active trials1 approved drugs
Loading cancer entity…
Cancer Family
CI-CAN-00000376Explore in graph →
Clinical trials
82 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03067181 | Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors | recruiting | Phase 3 | 1,780 | Children's Oncology GroupNETWORK | 9 | Aug 25, 2026 | clinicaltrials |
| NCT03703271 | Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia | recruiting | Phase 3 | 70 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT02375204 | Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors | active not recruiting | Phase 3 | 420 | Alliance for Clinical Trials in OncologyOTHER | 12 | Jun 16, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Aug 25, 2026source: clinicaltrials
| NCT01535053 | Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia | completed | Phase 3 | 57 | GOG FoundationNETWORK | 5 | Aug 12, 2022 | clinicaltrials |
| NCT05203562 | Letrozole as a Prophylaxis From GTN for Complete Mole Patients | unknown | Phase 2 / Phase 3 | 200 | Zagazig UniversityOTHER_GOV | 1 | Jul 12, 2022 | clinicaltrials |
| NCT02639650 | Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor | unknown | Phase 3 | 214 | Weiguo LvOTHER | 1 | Jun 3, 2022 | clinicaltrials |
| NCT04756713 | Second Uterine Evacuation for Low-risk Gestational Trophoblastic Neoplasia(ReCure) | unknown | Phase 3 | 150 | Brigham and Women's HospitalOTHER | 1 | May 27, 2022 | clinicaltrials |
| NCT01984099 | RCT on the Efficacy of Methotrexate for the Prevention of GTD | completed | Phase 3 | 99 | University of the PhilippinesOTHER | 1 | Apr 17, 2020 | clinicaltrials |
| NCT01823315 | Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia(GTN-01) | unknown | Phase 3 | 300 | Ding MaOTHER | 1 | Dec 24, 2019 | clinicaltrials |
| NCT03885388 | Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma (GTN) Patients With Score of 5-6 | unknown | Phase 2 / Phase 3 | 300 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Mar 21, 2019 | clinicaltrials |
| NCT00003702 | Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia | completed | Phase 3 | 240 | Gynecologic Oncology GroupNETWORK | 1 | May 15, 2018 | clinicaltrials |
| NCT03280979 | Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia | unknown | Phase 2 / Phase 3 | 170 | Assiut UniversityOTHER | 0 | Sep 13, 2017 | clinicaltrials |
| NCT00324324 | Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant | terminated | Phase 3 | 240 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT02606539 | Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms(SVCGTN) | unknown | Phase 2 / Phase 3 | 20 | Maher elesawi kamel elesawiOTHER | 1 | Mar 22, 2017 | clinicaltrials |
| NCT00058071 | Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer | completed | Phase 3 | 100 | Gynecologic Oncology GroupNETWORK | 1 | Jul 9, 2013 | clinicaltrials |